Bing Dai

1.1k total citations · 1 hit paper
23 papers, 638 citations indexed

About

Bing Dai is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cancer Research. According to data from OpenAlex, Bing Dai has authored 23 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Cancer Research. Recurrent topics in Bing Dai's work include Photoreceptor and optogenetics research (3 papers), Neural dynamics and brain function (3 papers) and Neurobiology and Insect Physiology Research (3 papers). Bing Dai is often cited by papers focused on Photoreceptor and optogenetics research (3 papers), Neural dynamics and brain function (3 papers) and Neurobiology and Insect Physiology Research (3 papers). Bing Dai collaborates with scholars based in China, United States and United Kingdom. Bing Dai's co-authors include Dayu Lin, Yulong Li, Fangmiao Sun, Tongrui Qian, Jianzhi Zeng, Yizhou Zhuo, Jiesi Feng, Ke Tan, Hui Dong and Yajun Zhang and has published in prestigious journals such as Nature, Cell and Neuron.

In The Last Decade

Bing Dai

22 papers receiving 629 citations

Hit Papers

Next-generation GRAB sensors for monitoring dopaminergic ... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Dai China 12 251 240 145 137 60 23 638
Ruiyu Wang China 15 226 0.9× 541 2.3× 125 0.9× 39 0.3× 58 1.0× 37 1.0k
Corey Smith United States 15 459 1.8× 734 3.1× 105 0.7× 79 0.6× 91 1.5× 28 1.2k
Karen J. Tonsfeldt United States 15 258 1.0× 222 0.9× 101 0.7× 109 0.8× 234 3.9× 33 819
Hirobumi Tada Japan 14 340 1.4× 290 1.2× 111 0.8× 88 0.6× 24 0.4× 26 721
Shu-Jing Li China 11 124 0.5× 167 0.7× 93 0.6× 129 0.9× 81 1.4× 21 467
Jingheng Zhou United States 13 624 2.5× 454 1.9× 340 2.3× 53 0.4× 74 1.2× 19 1.2k
Christian Schnell Germany 12 206 0.8× 226 0.9× 107 0.7× 108 0.8× 181 3.0× 21 779
Véronique Riban France 11 534 2.1× 262 1.1× 162 1.1× 31 0.2× 48 0.8× 17 988
Ke Tan China 10 213 0.8× 252 1.1× 92 0.6× 36 0.3× 27 0.5× 19 679

Countries citing papers authored by Bing Dai

Since Specialization
Citations

This map shows the geographic impact of Bing Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Dai more than expected).

Fields of papers citing papers by Bing Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Dai. The network helps show where Bing Dai may publish in the future.

Co-authorship network of co-authors of Bing Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Dai. A scholar is included among the top collaborators of Bing Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Dai. Bing Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Bing, X. Dai, X. F. Cui, et al.. (2025). Experience-dependent dopamine modulation of male aggression. Nature. 639(8054). 430–437. 11 indexed citations
2.
Dai, Bing & Dayu Lin. (2025). Dopamine modulation of aggression. Psychopharmacology.
3.
Liu, Henan, et al.. (2024). Synthetic approaches and application of representative clinically approved fluorine-enriched anti-cancer medications. European Journal of Medicinal Chemistry. 276. 116722–116722. 3 indexed citations
4.
Xia, Yu, Qingqing Chen, Henan Liu, et al.. (2024). Synthetic routes and clinical application of new drugs approved by EMA during 2023. European Journal of Medicinal Chemistry. 277. 116762–116762. 4 indexed citations
5.
Dai, Bing, et al.. (2024). Brain-wide multi-fiber recording of neuronal activity in freely moving mice. STAR Protocols. 5(1). 102882–102882. 2 indexed citations
6.
Yan, Rongzhen, et al.. (2024). The multi-stage plasticity in the aggression circuit underlying the winner effect. Cell. 187(24). 6785–6803.e18. 16 indexed citations
7.
Chen, Li, et al.. (2024). Efficacy and safety of omalizumab combined with allergen immunotherapy in children with moderate to severe allergic asthma. International Forum of Allergy & Rhinology. 15(2). 208–211. 2 indexed citations
8.
Osakada, Takuya, Rongzhen Yan, Yiwen Jiang, et al.. (2024). A dedicated hypothalamic oxytocin circuit controls aversive social learning. Nature. 626(7998). 347–356. 26 indexed citations
9.
Yin, Luping, Veronica Diaz, Bing Dai, et al.. (2023). Neural dynamics in the limbic system during male social behaviors. Neuron. 111(20). 3288–3306.e4. 29 indexed citations
10.
Dai, Bing, Fangmiao Sun, Xiaoyu Tong, et al.. (2022). Responses and functions of dopamine in nucleus accumbens core during social behaviors. Cell Reports. 40(8). 111246–111246. 85 indexed citations
11.
Dai, Bing, Hao Yu, Tingting Ma, et al.. (2021). The Application of Targeted RNA Sequencing for KMT2A–Partial Tandem Duplication Identification and Integrated Analysis of Molecular Characterization in Acute Myeloid Leukemia. Journal of Molecular Diagnostics. 23(11). 1478–1490. 6 indexed citations
12.
Sun, Fangmiao, Jingheng Zhou, Bing Dai, et al.. (2020). Next-generation GRAB sensors for monitoring dopaminergic activity in vivo. Nature Methods. 17(11). 1156–1166. 291 indexed citations breakdown →
13.
Tang, Ling, Hongkun Wang, Bing Dai, et al.. (2020). Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus. Journal of Molecular and Cellular Cardiology. 142. 53–64. 16 indexed citations
14.
Suebsuwong, Chalada, Bing Dai, Daniel M. Pinkas, et al.. (2020). Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold. European Journal of Medicinal Chemistry. 200. 112417–112417. 17 indexed citations
15.
Li, Lili, et al.. (2020). The activation of IL-17 signaling pathway promotes pyroptosis in pneumonia-induced sepsis. Annals of Translational Medicine. 8(11). 674–674. 52 indexed citations
16.
Suebsuwong, Chalada, Daniel M. Pinkas, Soumya S. Ray, et al.. (2018). Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(4). 577–583. 18 indexed citations
17.
Tang, Ling, Fang Yao, Hongkun Wang, et al.. (2018). Inhibition of TRPC1 prevents cardiac hypertrophy via NF-κB signaling pathway in human pluripotent stem cell-derived cardiomyocytes. Journal of Molecular and Cellular Cardiology. 126. 143–154. 18 indexed citations
18.
Roife, David, Bing Dai, Ya’an Kang, et al.. (2016). Auranofin to prevent progression of pancreatic ductal adenocarcinoma.. Journal of Clinical Oncology. 34(4_suppl). 236–236. 7 indexed citations
19.
Kang, Jian, et al.. (2009). [Expression and activation of hypoxia inducible factor-1alpha and iNOS in the brain of rats with chronic intermittent hypoxia].. PubMed. 32(10). 739–43. 4 indexed citations
20.
Zhao, Qing, et al.. (2004). Effect of transforming growth factor-beta on activity of connective tissue growth factor gene promoter in mouse NIH/3T3 fibroblasts.. PubMed. 25(4). 485–9. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026